Should the Incretin hype be the same for older adults: Promise + cautions.
Publication
, Journal Article
Batsis, JA; Porter Starr, KN; Villareal, DT
Published in: J Am Geriatr Soc
July 2024
Duke Scholars
Published In
J Am Geriatr Soc
DOI
EISSN
1532-5415
Publication Date
July 2024
Volume
72
Issue
7
Start / End Page
2266 / 2268
Location
United States
Related Subject Headings
- Incretins
- Hypoglycemic Agents
- Humans
- Glucagon-Like Peptide 1
- Geriatrics
- Diabetes Mellitus, Type 2
- Aged
- 52 Psychology
- 42 Health sciences
- 32 Biomedical and clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Batsis, J. A., Porter Starr, K. N., & Villareal, D. T. (2024). Should the Incretin hype be the same for older adults: Promise + cautions. J Am Geriatr Soc, 72(7), 2266–2268. https://doi.org/10.1111/jgs.18816
Batsis, John A., Kathryn N. Porter Starr, and Dennis T. Villareal. “Should the Incretin hype be the same for older adults: Promise + cautions.” J Am Geriatr Soc 72, no. 7 (July 2024): 2266–68. https://doi.org/10.1111/jgs.18816.
Batsis JA, Porter Starr KN, Villareal DT. Should the Incretin hype be the same for older adults: Promise + cautions. J Am Geriatr Soc. 2024 Jul;72(7):2266–8.
Batsis, John A., et al. “Should the Incretin hype be the same for older adults: Promise + cautions.” J Am Geriatr Soc, vol. 72, no. 7, July 2024, pp. 2266–68. Pubmed, doi:10.1111/jgs.18816.
Batsis JA, Porter Starr KN, Villareal DT. Should the Incretin hype be the same for older adults: Promise + cautions. J Am Geriatr Soc. 2024 Jul;72(7):2266–2268.
Published In
J Am Geriatr Soc
DOI
EISSN
1532-5415
Publication Date
July 2024
Volume
72
Issue
7
Start / End Page
2266 / 2268
Location
United States
Related Subject Headings
- Incretins
- Hypoglycemic Agents
- Humans
- Glucagon-Like Peptide 1
- Geriatrics
- Diabetes Mellitus, Type 2
- Aged
- 52 Psychology
- 42 Health sciences
- 32 Biomedical and clinical sciences